::: 김학동한의원 :::
ǿҰ
λ
ȳ
ãƿô±
¶λ
Ŀ´Ƽ Խ ѹĮ
 
 
ۼ : 22-11-30 21:11
>ħ(ħ)ġ Ѿġ ȣ '¼ Ӹ ' ȯ 1
 ۾ : е (222..117.60)
ȸ : 5,745  
   https://www.youtube.com/watch?v=DVBRF8L9mRM [2862]
   https://www.youtube.com/watch?v=MIZW5kOBKFk [2865]

ħ(ħ)ġ Ѿġ ȣ '¼ Ӹ ' ȯ 1
A case report of Acupotomy and Herbal Medicine Treatment for Patient with Essential Head Tremor.

Hagdong Kim , Daewon Shin
Correspondence to:Hagdong Kim
Kim hagdong Korean Medicine Clinic, 102/104, 3, Jungheung-ro 255beon-gi, Buk-gu, Pohang 37749, Korea
Tel: +82-54-278-7582
Fax: +82-54-278-7581
E-mail: hagdong@hanmail.com
Keywords Essential Head tremor, Acupotomy and Herbal Medicine Treatment, Case report

abstract
The aim of this study was to report the effect of acupotomy and herbal medicine treatment for patient with essential head tremor. One patient with essential head tremor was treated with acupotomy and herbal medicine. The patient reported that the tremor had been relived significantly. Acupotomy and Herbal medicine treatment is effective on Essential head tremor.

1. INTRODUCTION
  ü Ϻΰ Ҽ ֱ⸦ ̴ ̻ȯ ٸ ǥ ̻ȯ (myoclonus), ̻(dystonia), (chorea) ȴ. ̰ ª Ÿ ݰ ̻ȯ̰1,2) ̻ Ư ̰ ݺ Ͽ ü ̰ų Ʋ ̻ȯ̸2), ߵ ü ұĢ ġ ̰ų Ÿ ̻ ȯ̴3). ̷ ̻ȯ ٸ ۿ(agonist) ױ(antagonist) Ǵ ÿ Ͽ Ģ̰ 󵵸 ̸鼭 (sinusoidal) Ҽ ̴ ̻ȯ̴4)
 ¼ ̻ȯ ü α 0.7% ̰, ο ߻󵵰 ؼ 65 ̻ α 4.6% ȯ ִ5). ¼ ȯڿ ̰  Ÿ Ұ Ͽ ġḦ Ȱ ϰ ִ. α ȣƮ ϸ ¼ ȯ ġḦ ޴ ȯڴ 27% Ұ߰6), Ű 4% ġḦ ް ־7). ݸ, ¼ ϻȰɷ¿ ް ִ ȯڴ 73% Ǿ8). , ־ ȯ ν Ͽ ġḦ ʴ ȯڵ ̴.9)
  ¼ ġ ȣŰ ๰ġᰡ ⺻̴. θ ǰ ִ ๰ propranolol primidone̴. ̿ܿ Clonazepam, nadolol, sotalol, timolol, atenolol, phenobarbitone, alprazolam, topiramate, gabapentin ִ.(10,11)  Ϻ ¼ ȯڿ ſ ɰϿ ۾, Ļ, Ա ϻȰ ȥڼ ๰ ġῡ ʴ ɰ ȯڵ ִ. ̷ ȯڵ鿡 û(thalamus) nucleus ventralis intermedius ġ ɺڱ(deep brain stimulation)̳ ûı(thalamotomy) 12,13) ̳ Ȥ źп ۿ ִ. 14,15)
 , ü Ͽ ּħ ħġ, ħġ ȿ 䱸 ִ. ¼ ȯڸ ȸ(GV20), (EX-HN1), (LR3), հ(LI4), 縪õ(GB34), dz(GB20) ֿ ڸ ħġḦ RCT 8(ħ propranolol ġ 5, ܵħġ 3) Ÿм ȿ(Total Effective Rate, TER) ܵ propranolol ħġḦ ܵ ๰ Բ ġ ο Ұ ǹϰ Ǿ.16). ħġḦ ؼҼ̴.  2021 ħġḦ üӸ ġʿ 1 Ѵ. ش翬 Ʈ üӸ Ű αŰ ȭ ǥ ġߴ.17)
  ֺ ؼϿ ȯ Ű ¼ ҵ ̶ Ҵ. ׷ ӵ Ǯ ִ ħ ġ ַ ġ Ͽ. ȯڴ ħġḦ ϴ ӵ ȣ , ϱ⿡ ȣ ־. ٻ Ͽ Ƚ 1ȸ پ, ħ ġ ݵǴ   ڱط Ϲ ȣħ ġ ٲٸ鼭 ġ ӵ ȭ . ġ Ƚ ҿ ħ ڱط ҵ 3ְ ġ ġ޾Ҵ ʹ ȸ⿡ ġӵ ȸ Ǿ. ̸ ħġ ¼ ǹ ӻ ⿡ ̿ ϰ Ѵ.
 
2. CASE REPORT
2.1. ȯ
ȯڴ 54 ȯڷ 1 Ӹ ּ 2022 7 8 ġḦ Ͽ еǿ ߴ. ϻȰ ϴµ  溴 ʾҰ,  ġᰡ ó̶ ߴ. ش ȯڿ ħ, Ϲħ ġ ׸ ߳ġ ѾġḦ ߰ ߴ.
2.2. ȯ ׸
1 ۵ Ӹ ¿ Ű , , , ؼ ̾߱⸦ ϰ ָ ϸ ٰ ߴ. ȯ Ǹ ϰ Կ 78(1)м Ӹ ¿ 4~5Hz ֱ⸦ ټ . δ ħ ๰ 귯 ϴٰ Ͽ, 151/104 ټ Ǿ. ݱ ũ Ͱų ߴ , ϰ ִ , ð, Ϸ翡 ݰ ɴٰ Ͽ.
2.3. ġ
 22 7 8 22 10 14 ħġ 8ȸ, Ϲħ ġ 17ȸ, ߳ġ 4ȸ, ѾġḦ ߴ.(table 1) ȯڴ ׺ · ߴ. 6 ˻ ɵ  ־, ߻ ̻ ¶ Ǵߴ. ¼ Ӹ ȯ ȸ Ӹ ϴ ߺ ɸ Ͽ ̶ ħġ ϹħġḦ Ͽ ߴ. 4ȸ ߳ġ ߴ.
2.3.1. ħ, ħ, ߳ġ
ġ ׼(ιݱر semispinalis, ¸ trapezius, ĵϻﰢ, ǻ splenius ؼ), C1ȾC2ص(׼ ٴ, ĵ, ϵλ Myodural bridges_MDB ҹڸ ؼҷ ȯ ), C23( C2,3 İ; ۿ ϴ ؼ). , õ(¸, ߰ű ؼ), C1Ⱦ, C1Ⱦ, SCM, , ϵλ(ֺ ؼ), 󵹱(ֽŰġ) Ǿ ġ , ȯ 嵵 ȮϿ ߴ ġߴ.
  ħ ü 迭 ߺ dz() Ǯְ, ؼ Ű 嵵 Ǯֱ ؼ ߴ. 4ȸ ߳ġ JS߽ſ ַ Ͽ , Ǿ ִ ֺ ̿ϽŰ ġߴ.

Table1.Timeline of patient's treatments

2.3.2. Ѿ
شȯڴ ϸ ٰ ߴ. ؼְ, Ұϴ ó ַ Ͽ ÿ dz, û ǵ â(developing a new medicine)ߴ. 嵵 Ǯ鼭 7 25Ͽ Ա 뺯 Ѵ. ֺ. Ϸ 3 Ͽ, 縦 ٿֱ ؼ ó濡 Ű , , ߰ Ͽ 8 17 Ѿ ٲٰ ̶ Ͽ ־.

Table2. Composition of herbal medicine

2.4. ġ
  7 8 ġ '1' м ¿ Ӹ 4~5Hz(1ʿ 4ȸ 5ȸ ¿ ) .  8 2ϱ ħġ 4ȸ, 0.25mm*30mm ȣħġ 7ȸ '2'ó Կϴ 11ʰ ¿ Ӹ ҽǵǾ, 9 24ϱ ħġ 4ȸ, 0.25mm*30mm ȣħġ 4ȸ 0.2mm*30mm ȣħġ 3ȸ '3'ó 鸲 ° Կ 13ʰ Ǿ. 10 14ϱ ħġ 0ȸ, 0.2mm*30mm ȣħġ 3ȸ '4' 1 پ 4~5Hz ٽ ƿ Ǿ.
 1 2 ԿǴ ġ ù ȸ⿡ 1ȸ ħġ 2ȸ 0.25mm*30mm ȣħġḦ ޾, 2 3 ̸ ι° ȸ⿡ 82Ͽ 9 24ϱ 8ְ 4ȸ ħġḦ ޾ 0.5ȸ ħġ 1ȸ 0.2mm*30mm ȣħġḦ ޾Ҵ. 9 13 ħġḦ ' Ϲħ ַ Ͽ ġϰ ʹ' Ͽ ȯڴ 9 13 ķ 1ȸ ֱⰡ Ͽ. ħġ Ͽ źΰ Ÿ ġῡ ݵǴ ڱط ̱ 0.2mm*30mm ȣħġḸ ߴ.
 ȯڽ 82 Ӹ ε ϴٰ , 913Ϻ (Ϲ)ħġ Ͽ ġϰ ʹ١, 1014Ͽ ġ Ͽ 10->2 پ 鸰١ Ͽ Ӹ ȭ δ.
3. DISCUSSION AND CONCLUSION
ۿ(agonist) ױ(antagonist) Ǵ ÿ Ͽ Ģ̰ 󵵸 ̸鼭 (sinusoidal) Ҽ ̴ ̻ȯ̴4).
¼ ̻ȯ ü α 0.7% ̰, ο ߻󵵰 ؼ 65 ̻ α 4.6% ȯ ִ5). ¼ ȯڿ ̰  Ÿ Ұ Ͽ ġḦ Ȱ ϰ ִ. α ȣƮ ϸ ¼ ȯ ġḦ ޴ ȯڴ 27% Ұ߰6), Ű 4% ġḦ ް ־7). ݸ, ¼ ϻȰɷ¿ ް ִ ȯڴ 73% Ǿ8). , ־ ȯ ν Ͽ ġḦ ʴ ȯڵ ̴9).
¼ ȯ Ư üĿ Ǵ ˻ ŷ û Ű ܵȴ. ¼ ն 4-10 Hz  Ư¡ ̴. ն 鼭 Ӹ ִ ȯ ̻ ٸ ¼ зѴ18).
 ¼ ȯڸ ϰ ϱ ⺻ Ű ܿ ȴ. м Fahn-Tolosa-Marin tremor rating scale θ ǰ 19), ǿ κ ȯڿ ڼ ӻ ܿ ߿ϴ20).
 ¼ ȯڸ ִ Ų Ǵ Ųı ſ ߿ϴ. ¼ Ų Ǵ Ųı , ġ, ȯڿ ġ ſ ū ̸ ̱ Ȯ ߿ϴ. Ĺ Ű漼 ҽ θ Ǵ ִ Ĺοü([18F] fluorinated-N-3-fluoropropyl-2--carboxymethoxy-3--(4-iodophenyl)nortropane, [18F] FP-CIT PET) ˻簡 ʿ ִ21,22). [18F] FPCIT PET ˻翡 ¼ ȯڵ Ұ , Ų ȯڵ Ĺ Ű漼 Ҹ ûϴ Ұ Ȯϰ ִ. [18F] FP-CIT PET ִ Ƿ ſ ̱ , ӻ ؼ Ų ȯڿ ִ , , , Ҹ ȭ(hypophonia), ǥ (masked face), ۾ü ȭ(micrographia)  ʿϴ20).
¼ ġ ȣŰ ๰ġᰡ ⺻̴. θ ǰ ִ ๰ propranolol primidone̴. ̿ܿ Clonazepam, nadolol, sotalol, timolol, atenolol, phenobarbitone, alprazolam, topiramate, gabapentin ִ10,11). Ϻ ¼ ȯڿ ſ ɰϿ ۾, Ļ, Ա ϻȰ ȥڼ ๰ ġῡ ʴ ɰ ȯڵ ִ. ̷ ȯڵ鿡 û(thalamus) nucleus ventralis intermedius ġ ɺڱ(deep brain stimulation)̳ ûı(thalamotomy) 12,13) ̳ Ȥ źп ۿ ִ. 14,15)
 ¼ ؿ ȿ ġḦ ؼ ¼ Ư¡ ʿ䰡 ִ. A. Gironell ¼ ġϴ ڱ ҳ ޵Ǹ -aminobutyric acid (GABA) ̹Ƿ ȭȴٰ ߴ23). κ ¼ ҳ ǰ ̴24).
  ֺ ؼϿ ȯ Ű ¼ ҵ ̶ Ҵ. ׷ ӵ Ǯ ִ ħ ġ ַ ġ Ͽ. ȯڴ ħġḦ ϴ ӵ ȣ , ϱ⿡ ȣ ־. ٻ Ͽ Ƚ 1ȸ پ, ħ ġ ݵǴ   ڱط Ϲ ȣħ ġ ٲٸ鼭 ġ ӵ ȭ . ġ Ƚ ҿ ħ ڱط ҵ 3ְ ġ ġ޾Ҵ ʹ ȸ⿡ ġӵ ȸ Ǿ.
ȯڽ ȿ Ұ, ̶ , м ֵ ȣǾ ټ ȭ δ. ߺ ر Ǯ ¿ ġⰣ , ȿ ū ħġᰡ · ġḦ ٽ ݾ ȸ͵ ؼϿ. , ȯڿ Ͽ ġ ġȽ ȴٸ ¼ Ӹ ġᰡ ſ ǹ ȿ ȴ.
 
INFORMED CONSENT STATEMENT
Written informed consent has been obtained from the patient(s) to publish this paper.

AUTHOR CONTRIBUTIONS
HK-Writing original draft, DS-Reviewing and editing.

CONFLICTS OF INTEREST
The authors declare no conflict of interest

ORCID
Hagdong Kim, https://orcid.org/0000-0002-5954-2045
Daewon Shin, https://orcid.org/0000-0002-1269-5773

References
1. Shibasaki H, Thompson PD. Milestones in myoclonus. Mov Disord 2011;26:1142-1148.
2. Ozelius LJ, Lubarr N, Bressman SB. Milestones in dystonia. Mov Disord 2011;26:1106-1126.
3. Cardoso F, Seppi K, Mair KJ, Wenning GK, Poewe W. Seminar on choreas. Lancet Neurol 2006;5:589-602.
4. Elble R, Deuschl G. Milestones in tremor research. Mov Disord 2011;26:1096-1105.
5. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010;25:534-541.
6. Lorenz D, Poremba C, Papengut F, Schreiber S, Deuschl G. The psychosocial burden of essential tremor in an outpatientand a community-based cohort. Eur J Neurol 2011;18:972-979.
7. Dogu O, Louis ED, Sevim S, Kaleagasi H, Aral M. Clinical characteristics of essential tremor in Mersin, Turkey: a populationbased door-to-door study. J Neurol 2005;252:570-574.
8. Louis ED, Barnes L, Albert SM, Cote L, Schneier FR, Pullman SL, Yu Q. Correlates of functional disability in essential tremor. Mov Disord 2001;16:914-920.
9. Raethjen J, Deuschl G. Tremor. Curr Opin Neurol 2009; 22: 400-405.
10. Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. Lancet Neurol 2011;10:148-161.
11. Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB Jr, Okun MS, Sullivan KL, Weiner WJ. Evidencebased guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2011;77:1752-1755.
12. Koller WC, Pahwa PR, Lyons KE, Wilkinson SB. Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor. Neurology 2000;55(12 Suppl 6):S29-S33.
13. Schuurman PR, Bosch DA, Bossuyt PM, Bonsel GJ, van Someren EJ, de Bie RM, Merkus MP, Speelman JD. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000;342: 461-468.
14. T.A. Zesiewicz, R. Elble, E.D. Louis, R.A. Hauser, K.L. Sullivan, R.B. Dewey, Jr., et al., Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology; vol. 64, pp. 2008-2020, 2005
15. Kringelbach ML, Jenkinson N, Owen SLF, Aziz TZ. Translational principles of deep brain stimulation. Nature Reviews Neuroscience 2007;8:623-35.
16. YJ Sohn, SY Jung. A Meta-analysis of the Effectiveness of Acupuncture for the Treatment of Essential Tremors. J Int Korean Med. 2017; 38(4):419-432
17. KH Lim, GC Kim. A Case Report of Acupotomy and Herbal Medicine Treatment for Patient with Head Tremor. JKMST 2021; 5(2): 149-153
18. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998;13 Suppl 3:2-23.
19. Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, editors. Parkinsons disease and movement disorders. 2nd ed. Baltimore: Williiams & Wilkins; 1993. p. 271-280.
20. SJ Chung. Diagnosis and treatment of hand tremor. J Korean Med Assoc 2012 October; 55(10): 987-995
21.  Stoessl AJ, Martin WW, McKeown MJ, Sossi V. Advances in imaging in Parkinsons disease. Lancet Neurol 2011;10:9871001.
22.  Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, Moon DH, Oh SJ, Chung SJ, Lee CS. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
J Nucl Med 2012;53:399-406.
23. A. Gironell, J. Kulisevsky, J. Lorenzo, M. Barbanoj, B. Pascual-Sedano and P. Otermin, Transcranial magnetic stimulation of the cerebellum in essential tremor: a controlled study, Archives of neurology, vol. 59, pp. 413-417, 2002.
24. K.C. Brennan, E.C. Jurewicz, B. Ford, S.L. Pullman, and E.D. Louis, Is essential tremor predominantly a kinetic or a postural tremor? A clinical and electrophysiological study,Mov Disord, vol. 17, no. 2, pp. 313-316, 2002.
25. Ѿǥڿ https://oasis.kiom.re.kr/herblib/hminfo/kmdmt/kmdmtDetail.do
26. Hagdong Kim. еǿ ¼ Ӹ 1 (22.07.08)[Video].YouTube.https://www.youtube.com/watch?v=DVBRF8L9mRM. Published October 28, 2022.
27. Hagdong Kim. еǿ ¼ Ӹ 2 (22.08.02)[Video].YouTube.https://www.youtube.com/watch?v=MIZW5kOBKFk. Published October 28, 2022.
28. Hagdong Kim. еǿ ¼ Ӹ 3 (22.09.24)[Video].YouTube.https://www.youtube.com/watch?v=j3cEA3K8d0M. Published October 28, 2022.
29. Hagdong Kim. еǿ ¼ Ӹ 4 (22.10.14)[Video].YouTube.https://www.youtube.com/watch?v=y_rvZhgungY. Published October 28, 2022.

 
   
 

관리자로그인